Target intelligence / Profile preview

Angiotensin II Type 1 Receptor β-Arrestin Pathway (AT1R β-arrestin pathway)

Target
AT1R β-arrestin pathway
Molecular classification
G protein-coupled receptor pathway, Signal transduction pathway
01

Overview

The Angiotensin II type 1 receptor (AT1R) β-arrestin pathway is a signaling cascade initiated by angiotensin II binding to the AT1R, a G protein-coupled receptor. This pathway involves the recruitment of β-arrestins, which desensitize G protein signaling and initiate distinct intracellular signaling cascades, including MAPK activation. This pathway plays a critical role in cardiovascular regulation and is implicated in various cardiovascular diseases. Selective modulation of this pathway is being explored for therapeutic potential.

Other names
AT1R beta-arrestin signalingAngiotensin Receptor Type 1 Beta-arrestin pathwayAGTR1 beta-arrestin pathway
02

Mechanism of action

Activation of β-arrestin signaling upon AT1R stimulation, leading to receptor internalization, desensitization of G protein signaling, and activation of alternative downstream signaling cascades (e.g., MAPK pathways).

03

Biological functions

Signal transductionReceptor internalizationMAPK signalingCalcium signalingRegulation of blood pressureRegulation of fluid balanceCardiovascular regulationG protein-independent signaling
04

Disease associations

HypertensionHeart failureAtherosclerosisPulmonary arterial hypertensionMyocardial hypertrophyCardiac dysfunctionVascular remodeling
05

Safety considerations

Potential for biased agonism to elicit unexpected effectsDysregulation can lead to pathological vascular remodeling
06

Interacting drugs

Angiotensin II

2 more in the full profile.

Beyond the preview

Go deeper on Angiotensin II Type 1 Receptor β-Arrestin Pathway (AT1R β-arrestin pathway).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Angiotensin II Type 1 Receptor β-Arrestin Pathway (AT1R β-arrestin pathway).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call